EHCEncompass Health Corp

NYSE encompasshealth.com


$ 86.55 $ 0.16 (0.19 %)    

Friday, 10-May-2024 15:59:56 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 86.53
$ 86.40
$ 0.00 x 0
$ 0.00 x 0
$ 85.90 - $ 86.61
$ 57.31 - $ 86.72
719,298
na
8.84B
$ 1.05
$ 23.47
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-01-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-01-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-03-2023 03-31-2023 10-Q
6 02-27-2023 12-31-2022 10-K
7 11-02-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-03-2022 03-31-2022 10-Q
10 02-25-2022 12-31-2021 10-K
11 11-02-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 02-26-2021 12-31-2020 10-K
15 11-02-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 07-31-2019 06-30-2019 10-Q
21 05-01-2019 03-31-2019 10-Q
22 02-27-2019 12-31-2018 10-K
23 10-31-2018 09-30-2018 10-Q
24 08-02-2018 06-30-2018 10-Q
25 05-02-2018 03-31-2018 10-Q
26 02-28-2018 12-31-2017 10-K
27 10-31-2017 09-30-2017 10-Q
28 08-02-2017 06-30-2017 10-Q
29 04-28-2017 03-31-2017 10-Q
30 02-22-2017 12-31-2016 10-K
31 10-28-2016 09-30-2016 10-Q
32 07-29-2016 06-30-2016 10-Q
33 04-28-2016 03-31-2016 10-Q
34 02-25-2016 12-31-2015 10-K
35 10-29-2015 09-30-2015 10-Q
36 07-30-2015 06-30-2015 10-Q
37 05-01-2015 03-31-2015 10-Q
38 03-02-2015 12-31-2014 10-K
39 10-28-2014 09-30-2014 10-Q
40 07-29-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 raymond-james-reiterates-strong-buy-on-encompass-health-raises-price-target-to-95

Raymond James analyst John Ransom reiterates Encompass Health (NYSE:EHC) with a Strong Buy and raises the price target from ...

 barclays-maintains-overweight-on-encompass-health-raises-price-target-to-108

Barclays analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Overweight and raises the price target from $101 to...

 mizuho-maintains-buy-on-encompass-health-raises-price-target-to-95

Mizuho analyst Ann Hynes maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $93 to $95.

 encompass-health-q1-2024-adj-eps-112-beats-094-estimate-sales-1316b-beat-1273b-estimate

Encompass Health (NYSE:EHC) reported quarterly earnings of $1.12 per share which beat the analyst consensus estimate of $0.94 b...

 encompass-health-announces-preliminary-plans-to-build-a-50-bed-inpatient-rehabilitation-hospital-in-san-antonio

Encompass Health Corp. (NYSE:EHC) today announced preliminary plans to build a freestanding, 50-bed inpatient rehabilitation ho...

 rex-american-resources-reports-upbeat-earnings-joins-avalo-therapeutics-rh-and-other-big-stocks-moving-higher-on-thursday

U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corpo...

 barclays-maintains-overweight-on-encompass-health-raises-price-target-to-101

Barclays analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Overweight and raises the price target from $95 to ...

 barclays-initiates-coverage-on-encompass-health-with-overweight-rating-announces-price-target-of-95

Barclays analyst Andrew Mok initiates coverage on Encompass Health (NYSE:EHC) with a Overweight rating and announces Price T...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION